Large-scale CSF proteome profiling identifies biomarkers for accurate diagnosis of frontotemporal dementia.

Mol Neurodegener · 2025 · PMC12392567 · PMID 40866991

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nominally significantno p-value reported

Notably, we observed a number of proteins with nominally significant differences across the FTLD subtypes, suggesting that larger, more powered studies may reveal additional subtype-specific biomarkers.

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.